United States · FDA National Drug Code directory
Meloxicam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71610-544_dbe2faa6-75ee-4c6d-9bd9-c91b63851a25
- Product NDC
- 71610-544
- Form
- TABLET
- Composition / generic term
- Meloxicam
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200217
- Source listing expiry
- 20261231
Source-listed ingredients
- MELOXICAM — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (71610-544-30) · 71610-544-30
- 60 TABLET in 1 BOTTLE (71610-544-53) · 71610-544-53
- 90 TABLET in 1 BOTTLE (71610-544-60) · 71610-544-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →